NCT03322618View on ClinicalTrials.gov

Evaluation of the Expression and Functions of the KIR3DL2 Receptor and the Anti-inflammatory Activity of IPH4102 in Blood Samples

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 18, 2017

Primary Completion Date

September 17, 2019

Study Completion Date

September 17, 2019

Conditions
Axial Spondyloarthritis (axSpA)Ankylosing Spondylitis (AS)
Interventions
BIOLOGICAL

blood samples

7 tubes of 6 ml (42 ml of blood )

Trial Locations (1)

13354

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT03322618 - Evaluation of the Expression and Functions of the KIR3DL2 Receptor and the Anti-inflammatory Activity of IPH4102 in Blood Samples | Biotech Hunter | Biotech Hunter